Table 7.
Clinical characteristics of PD subjects.
| Patients | Sex | Age | Education (years) |
Disease Duration (years) | Familiarity | Affected Side | UPDRS III † | Therapy LEDD †† | Disorders of Behaviour |
|---|---|---|---|---|---|---|---|---|---|
| PD1 | F | 70 | NA | 8 | No | Right | 12 | 350 | No |
| PD2 | M | 73 | NA | 7 | Yes | Right | 10 | 320 | ICD |
| PD3 | M | 68 | 8 | 19 | No | Left | 44 | 800 | ICD |
| PD4 | M | 69 | NA | 13 | Yes | Right | 18 | 500 | No |
| PD5 | F | 73 | 8 | 10 | Yes | Right | 17 | 1000 | No |
| PD6 | M | 76 | NA | 7 | No | Right | 18 | 650 | No |
| PD7 | F | 68 | NA | 6 | No | Right | 20 | 600 | No |
| PD8 | M | 76 | 8 | 13 | Yes | Left | 35 | 690 | No |
| PD9 | F | 73 | NA | 13 | Yes | Left | 15 | 350 | ICD |
PD = Parkinson Disease; † UPDRS III = Unified Parkinson’s disease Rating Scale-motor part. Patients where tested during the ON phase; †† Therapy LEDD: levodopa equivalent daily dose (LEDD), mg/day; NA = not available; ICD = Impulse Control Disorders.